About EXIT071

EXIT071 develops technology to hack intercellular communication. Their microfluidic technology is applied for the analysis of exosomes in therapeutics and diagnostics.

Company Highlights
Year Founded

2021

icon-altEmployees

5

Location (HQ)

NLD

Since Last Funding

2 years 6 months

Monthly Website Visitors

142

icon-altTotal Investment Amt

$400K

Last Funding Round

Seed

icon-altMoM Headcount Growth

-16.39%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Pharmaceutical

Therapeutics

Biopharma